These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 17289470
41. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD. J Immunol; 1990 Feb 01; 144(3):909-15. PubMed ID: 1688591 [Abstract] [Full Text] [Related]
43. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Katsara M, Deraos S, Tselios TV, Pietersz G, Matsoukas J, Apostolopoulos V. Immunotherapy; 2014 Feb 01; 6(6):709-24. PubMed ID: 25186603 [Abstract] [Full Text] [Related]
49. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. Legge KL, Min B, Bell JJ, Caprio JC, Li L, Gregg RK, Zaghouani H. J Exp Med; 2000 Jun 19; 191(12):2039-52. PubMed ID: 10859329 [Abstract] [Full Text] [Related]
50. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Robinson AP, Harp CT, Noronha A, Miller SD. Handb Clin Neurol; 2014 Jun 19; 122():173-89. PubMed ID: 24507518 [Abstract] [Full Text] [Related]
55. Dual peptide nanoparticle platform for enhanced antigen-specific immune tolerance for the treatment of experimental autoimmune encephalomyelitis. Wang H, Shang J, He Z, Zheng M, Jia H, Zhang Y, Yang W, Gao X, Gao F. Biomater Sci; 2022 Jul 12; 10(14):3878-3891. PubMed ID: 35686489 [Abstract] [Full Text] [Related]
56. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Lutterotti A, Yousef S, Sputtek A, Stürner KH, Stellmann JP, Breiden P, Reinhardt S, Schulze C, Bester M, Heesen C, Schippling S, Miller SD, Sospedra M, Martin R. Sci Transl Med; 2013 Jun 05; 5(188):188ra75. PubMed ID: 23740901 [Abstract] [Full Text] [Related]
57. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. Davies S, Nicholson T, Laura M, Giovannoni G, Altmann DM. J Neuropathol Exp Neurol; 2005 May 05; 64(5):371-7. PubMed ID: 15892293 [Abstract] [Full Text] [Related]
59. Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis. Massey EJ, Sundstedt A, Day MJ, Corfield G, Anderton S, Wraith DC. Vet Immunol Immunopathol; 2002 Sep 10; 87(3-4):357-72. PubMed ID: 12072259 [Abstract] [Full Text] [Related]
60. The effect of intrathecal MBP synthetic peptides containing epitope P85 VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis. Warren KG, Catz I. J Neurol Sci; 1997 May 01; 148(1):67-78. PubMed ID: 9125392 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]